Correlation Between Inhibrx and Silvaco Group,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Silvaco Group, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Silvaco Group, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Silvaco Group, Common, you can compare the effects of market volatilities on Inhibrx and Silvaco Group, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Silvaco Group,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Silvaco Group,.

Diversification Opportunities for Inhibrx and Silvaco Group,

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Inhibrx and Silvaco is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Silvaco Group, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silvaco Group, Common and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Silvaco Group,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silvaco Group, Common has no effect on the direction of Inhibrx i.e., Inhibrx and Silvaco Group, go up and down completely randomly.

Pair Corralation between Inhibrx and Silvaco Group,

Given the investment horizon of 90 days Inhibrx is expected to under-perform the Silvaco Group,. In addition to that, Inhibrx is 1.32 times more volatile than Silvaco Group, Common. It trades about -0.11 of its total potential returns per unit of risk. Silvaco Group, Common is currently generating about 0.11 per unit of volatility. If you would invest  797.00  in Silvaco Group, Common on October 25, 2024 and sell it today you would earn a total of  46.00  from holding Silvaco Group, Common or generate 5.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Inhibrx  vs.  Silvaco Group, Common

 Performance 
       Timeline  
Inhibrx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Silvaco Group, Common 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Silvaco Group, Common are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting fundamental indicators, Silvaco Group, displayed solid returns over the last few months and may actually be approaching a breakup point.

Inhibrx and Silvaco Group, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inhibrx and Silvaco Group,

The main advantage of trading using opposite Inhibrx and Silvaco Group, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Silvaco Group, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silvaco Group, will offset losses from the drop in Silvaco Group,'s long position.
The idea behind Inhibrx and Silvaco Group, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios